Breaking Finance News

Plant Health Care PLC (LON:PHC) has been reiterated to Buy in a report by Liberum Capital today.

Just yesterday Plant Health Care PLC (LON:PHC) traded -2.86% lower at 29.50GBX. Plant Health Care PLC’s 50-day moving average is 26.52GBX and its 200-day moving average is 26.23GBX. The last stock price is up -2.79% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.04% over the same time period. 6,004 shares of PHC traded hands, down from an average trading volume of 70,776

Liberum Capital has reiterated Plant Health Care PLC (LON:PHC) to Buy in a report released on Monday June 19, 2017.

Previously on 06/12/2017, Liberum Capital released a statement about Plant Health Care PLC (LON:PHC) held steady the target price at 50.00GBX. At the time, this indicated a possible upside of 0.69%.

Recent Performance Chart

Plant Health Care PLC (LON:PHC)

Plant Health Care PLC has 52 week low of 13.00GBX and a 52 week high of 35.00GBX and has a market capitalization of 0 GBX.

In addition to Liberum Capital reporting its stock price target, a total of 1 brokerage has issued a ratings update on the company. The average stock price target is 176.33GBX with 1 brokerage rating the stock a strong buy, 0 brokerages rating the stock a buy, 0 brokerages rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.

Brief Synopsis On Plant Health Care PLC (LON:PHC)

Plant Health Care plc provides agricultural biological products and technology solutions. The Company's segments include Americas, Mexico, Rest of World and New Technology. The Company focuses on businesses, including New Technology and Commercial. Its Commercial business is focused on the sale of biological products. Its products are categorized as biofertilizers and biostimulants. Its product portfolio is mainly based on Harpin technology. The Commercial business sells its products across the world through distributors and distributes complementary third-party products in Mexico. The Commercial business includes geographic segments, such as the Americas, Mexico and Rest of World. The New Technology segment is focused on the research and development of its Plant Response Elicitor technology (PREtec) platform. The PREtec platform identifies families of peptides that provide crop treatment options for growers that are complementary to existing agricultural technologies and practices.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.